These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 28249208)

  • 1. Diphenylurea derivatives for combating methicillin- and vancomycin-resistant Staphylococcus aureus.
    Eissa IH; Mohammad H; Qassem OA; Younis W; Abdelghany TM; Elshafeey A; Abd Rabo Moustafa MM; Seleem MN; Mayhoub AS
    Eur J Med Chem; 2017 Apr; 130():73-85. PubMed ID: 28249208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the structure-activity relationships of diphenylurea as an antibacterial scaffold active against methicillin- and vancomycin-resistant Staphylococcus aureus.
    Elsebaie MM; Nour El-Din HT; Abutaleb NS; Abuelkhir AA; Liang HW; Attia AS; Seleem MN; Mayhoub AS
    Eur J Med Chem; 2022 Apr; 234():114204. PubMed ID: 35279608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteriological profiling of diphenylureas as a novel class of antibiotics against methicillin-resistant Staphylococcus aureus.
    Mohammad H; Younis W; Ezzat HG; Peters CE; AbdelKhalek A; Cooper B; Pogliano K; Pogliano J; Mayhoub AS; Seleem MN
    PLoS One; 2017; 12(8):e0182821. PubMed ID: 28797064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
    Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
    J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growing Resistance to Vancomycin among Methicillin Resistant Staphylococcus Aureus Isolates from Different Clinical Samples.
    Pahadi PC; Shrestha UT; Adhikari N; Shah PK; Amatya R
    JNMA J Nepal Med Assoc; 2014; 52(196):977-81. PubMed ID: 26982895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of novel piperonyl derivatives as diapophytoene desaturase inhibitors for the treatment of methicillin-, vancomycin- and linezolid-resistant Staphylococcus aureus infections.
    Wei H; Mao F; Ni S; Chen F; Li B; Qiu X; Hu L; Wang M; Zheng X; Zhu J; Lan L; Li J
    Eur J Med Chem; 2018 Feb; 145():235-251. PubMed ID: 29328999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Inhibitors of Staphyloxanthin Virulence Factor in Comparison with Linezolid and Vancomycin versus Methicillin-Resistant, Linezolid-Resistant, and Vancomycin-Intermediate Staphylococcus aureus Infections in Vivo.
    Ni S; Wei H; Li B; Chen F; Liu Y; Chen W; Xu Y; Qiu X; Li X; Lu Y; Liu W; Hu L; Lin D; Wang M; Zheng X; Mao F; Zhu J; Lan L; Li J
    J Med Chem; 2017 Oct; 60(19):8145-8159. PubMed ID: 28880552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and characterization of aryl isonitriles as a new class of compounds versus methicillin- and vancomycin-resistant Staphylococcus aureus.
    Davis DC; Mohammad H; Kyei-Baffour K; Younis W; Creemer CN; Seleem MN; Dai M
    Eur J Med Chem; 2015 Aug; 101():384-90. PubMed ID: 26164843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Neutrally Charged Diarylurea Compound PQ401 Kills Antibiotic-Resistant and Antibiotic-Tolerant Staphylococcus aureus.
    Kim W; Zou G; Pan W; Fricke N; Faizi HA; Kim SM; Khader R; Li S; Lee K; Escorba I; Vlahovska PM; Gao H; Ausubel FM; Mylonakis E
    mBio; 2020 Jun; 11(3):. PubMed ID: 32605985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and Syntheses of Highly Potent Teixobactin Analogues against Staphylococcus aureus, Methicillin-Resistant Staphylococcus aureus (MRSA), and Vancomycin-Resistant Enterococci (VRE) in Vitro and in Vivo.
    Parmar A; Lakshminarayanan R; Iyer A; Mayandi V; Leng Goh ET; Lloyd DG; Chalasani MLS; Verma NK; Prior SH; Beuerman RW; Madder A; Taylor EJ; Singh I
    J Med Chem; 2018 Mar; 61(5):2009-2017. PubMed ID: 29363971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of new 3-phenylquinazolin-4(3H)-one derivatives as potent antibacterial agents effective against methicillin- and vancomycin-resistant Staphylococcus aureus (MRSA and VRSA).
    Gatadi S; Gour J; Kaul G; Shukla M; Dasgupta A; Akunuri R; Tripathi R; Madhavi YV; Chopra S; Nanduri S
    Bioorg Chem; 2018 Dec; 81():175-183. PubMed ID: 30130650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid-phase synthesis and antibacterial activity of hydroxycinnamic acid amides and analogues against methicillin-resistant Staphylococcus aureus and vancomycin-resistant S. aureus.
    Yingyongnarongkul BE; Apiratikul N; Aroonrerk N; Suksamrarn A
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5870-3. PubMed ID: 16942872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating the Antibacterial Activity of Biphenylthiazoles against Methicillin- and Vancomycin-Resistant Staphylococcus aureus (MRSA and VRSA).
    Hagras M; Mohammad H; Mandour MS; Hegazy YA; Ghiaty A; Seleem MN; Mayhoub AS
    J Med Chem; 2017 May; 60(9):4074-4085. PubMed ID: 28436655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic Resistance in the Treatment of Staphylococcus aureus Keratitis: a 20-Year Review.
    Chang VS; Dhaliwal DK; Raju L; Kowalski RP
    Cornea; 2015 Jun; 34(6):698-703. PubMed ID: 25811722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential Evolution of Vancomycin-Intermediate Resistance Alters Virulence in Staphylococcus aureus: Pharmacokinetic/Pharmacodynamic Targets for Vancomycin Exposure.
    Lenhard JR; Brown T; Rybak MJ; Meaney CJ; Norgard NB; Bulman ZP; Brazeau DA; Gill SR; Tsuji BT
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1584-91. PubMed ID: 26711763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of N-phenyl-2-aminothiazoles for treatment of multi-drug resistant and intracellular Staphylococcus aureus infections.
    Shahin IG; Abutaleb NS; Alhashimi M; Kassab AE; Mohamed KO; Taher AT; Seleem MN; Mayhoub AS
    Eur J Med Chem; 2020 Sep; 202():112497. PubMed ID: 32707373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.
    Sakoulas G; Moellering RC
    Clin Infect Dis; 2008 Jun; 46 Suppl 5():S360-7. PubMed ID: 18462091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antibacterial and anti-biofilm activity of gold-complexed sulfonamides against methicillin-resistant Staphylococcus aureus.
    Mizdal CR; Stefanello ST; da Costa Flores V; Agertt VA; Bonez PC; Rossi GG; da Silva TC; Antunes Soares FA; de Lourenço Marques L; de Campos MMA
    Microb Pathog; 2018 Oct; 123():440-448. PubMed ID: 30086343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of new norfloxacin-1,3,4-oxadiazole hybrids as antibacterial agents against methicillin-resistant Staphylococcus aureus (MRSA).
    Guo Y; Xu T; Bao C; Liu Z; Fan J; Yang R; Qin S
    Eur J Pharm Sci; 2019 Aug; 136():104966. PubMed ID: 31233865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alkynyl-containing phenylthiazoles: Systemically active antibacterial agents effective against methicillin-resistant Staphylococcus aureus (MRSA).
    Elsebaei MM; Mohammad H; Abouf M; Abutaleb NS; Hegazy YA; Ghiaty A; Chen L; Zhang J; Malwal SR; Oldfield E; Seleem MN; Mayhoub AS
    Eur J Med Chem; 2018 Mar; 148():195-209. PubMed ID: 29459278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.